α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies
Conclusions: CSF α‐synuclein species could be useful as part of a biomarker panel for dementia with Lewy bodies. Evaluating both oligomeric α‐synuclein and total α‐synuclein in CSF helps in the diagnosis of dementia with Lewy bodies. © 2018 The Authors.Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
Source: Movement Disorders - Category: Neurology Authors: Inger Steenoven,
Nour K. Majbour,
Nishant N. Vaikath,
Henk W. Berendse,
Wiesje M. Flier,
Wilma D.J. Berg,
Charlotte E. Teunissen,
Afina W. Lemstra,
Omar M.A. El ‐Agnaf Tags: Research Article Source Type: research